LILEE ROBINSON: Open Payments
NPI 1174244602 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 10 payments from 5 companies in 2025. Trend: 2023 $552 · 2024 $91 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Novo Nordisk Inc | 2 | $55 |
| Alkermes, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
Products named: ARISTADA, CAPLYTA, ABILIFY MAINTENA, Ozempic, FANAPT, Rybelsus, REXULTI.
Industry payments across IL — which companies pay providers there.
